Form 4: QuidelOrtho Director Kenneth J. Widder Reports Stock Transactions

Director Kenneth J. Widder reports the release of restricted stock units and subsequent ownership of common stock in QuidelOrtho Corp.

Summary

• On May 24, 2024, Kenneth J. Widder, a director of QuidelOrtho Corp, reported transactions involving the company's common stock.
• Widder acquired 2,416 shares of common stock upon the vesting of restricted stock units.
• These restricted stock units were previously reported on a Form 4.
• Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
• Following the transaction, Widder directly owns 25,139 shares of QuidelOrtho Corp.
• The restricted stock units vested on May 24, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The vesting of restricted stock units is generally a positive sign, but it's not a major event.

Positives

• The vesting of restricted stock units indicates that performance milestones were likely met, which is a positive signal.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing Widder's holdings to those of other directors in similar diagnostic companies like Abbott Laboratories (ABT) or Roche (RHHBY) could provide context on the magnitude of his investment.
• Equity grants are a common form of compensation in the biotech and diagnostics industry, used to align management's interests with those of shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates